Microbiologics Inc, St. Cloud, Minn, has expanded its line of Helix Elite molecular standards with the addition of inactivated extraction controls. The fully intact process controls are used for validation, verification, proficiency testing, and quality control of molecular assays. FDA-cleared and CE-marked in vitro diagnostic medical devices for use in clinical laboratories, the non-viable viral and bacterial targets are produced in the form of lyophilized pellets, which are shipped and stored at room temperature. The quick-dissolving pellets may be reconstituted in relevant buffers or transport media and then processed using the same protocols as the patient sample. Respiratory and gastrointestinal targets are available immediately, with additional respiratory and sexually transmitted disease targets being added throughout the year. For more information, visit Microbiologics.
Large Prospective Lung Cancer Study to Be Presented at ESMO
September 14, 2020
Jenoptik Debuts Miniaturized Imaging Platform
March 7, 2018